Grafa News and Videos — Page 529

JPMorgan (NYSE:JPM) has voiced its support for the CLARITY Act, a legislative proposal aimed at establishing clearer regulatory rules for digital assets in the United States.

Artelo Biosciences (NASDAQ:ARTL) reported new preclinical data for ART26.12, a selective FABP5 inhibitor currently in Phase 1 development, in a mouse model of spinal cord injury–related neuropathic pain.

Micron (NASDAQ:MU) and General Motors (NYSE:GM) signed a Strategic Customer Agreement to secure long-term supply of automotive memory and storage for GM’s next-generation vehicle platforms

60 Degrees Pharma (NASDAQ:SXTP) reported that an independent Data Safety Monitoring Board found no safety concerns in the first six patients in its Phase 2 B-Free chronic babesiosis study and recommended trial continuation.

Himax Technologies (Nasdaq:HIMX) said it plans to dispose of its investment in an equity-method investee after the startup agreed to be acquired by a third-party semiconductor company for $80 million in cash.

BTQ (NASDAQ:BTQ) received final approval from French foreign direct investment authorities to acquire all remaining shares of QPerfect, a quantum software company based in Strasbourg.

Vyome Holdings (NASDAQ:HIND) said the China National Intellectual Property Administration granted a patent covering formulation and therapeutic uses for its besifloxacin topical gel program.

Arrow Financial (NASDAQ:AROW) announced the completion of its strategic acquisition of Adirondack Bancorp and the merger of Adirondack Bank into Arrow Bank National Association.

FactSet (NYSE:FDS) reported third-quarter fiscal 2026 revenue of $622.9 million, representing a 6.4% increase year over year with 7% organic revenue growth.

Intensity Therapeutics (NASDAQ:INTS) issued a mid-year 2026 update on its intratumoral cancer therapy INT230-6, highlighting progress across late-stage clinical programs.